Description

59,71,920 equity shares of BANDARAM PHARMA PACKTECH LIMITED listed on BSE with effect from December 16, 2025, issued on preferential basis to promoters and non-promoters.

Summary

BSE has listed 59,71,920 new equity shares of BANDARAM PHARMA PACKTECH LIMITED (Scrip Code: 524602) with effect from December 16, 2025. These shares were issued at Rs. 20/- per share (face value Rs. 10/- plus premium of Rs. 10/-) on a preferential basis to promoters and non-promoters. The allotment date was November 6, 2025, and the shares rank pari-passu with existing equity shares.

Key Points

  • Total shares listed: 59,71,920 equity shares of Rs. 10/- each
  • Issue price: Rs. 20/- per share (including premium of Rs. 10/-)
  • Scrip Code: 524602
  • ISIN: INE875N01036
  • Trading commencement: December 16, 2025
  • Allotment date: November 6, 2025
  • Distinctive Numbers: 12000001 to 17971920
  • Shares rank pari-passu with existing equity shares

Regulatory Changes

No regulatory changes. This is a routine listing notification for preferential allotment.

Compliance Requirements

Trading members must note the lock-in provisions applicable to the newly listed securities:

  • 22,54,484 shares (Dist. Nos. 12000001 to 14254484) are locked-in until June 30, 2027
  • 37,17,436 shares (Dist. Nos. 14254485 to 17971920) are locked-in until June 30, 2026

Important Dates

  • Allotment Date: November 6, 2025
  • Trading Commencement: December 16, 2025
  • Lock-in Expiry (Batch 1): June 30, 2026 (37,17,436 shares)
  • Lock-in Expiry (Batch 2): June 30, 2027 (22,54,484 shares)

Impact Assessment

This listing has minimal market-wide impact as it pertains to a single company’s preferential allotment. The lock-in periods ensure that these shares cannot be traded immediately, limiting liquidity impact. The issuance to promoters and non-promoters on preferential basis is a standard capital raising mechanism. Trading members should be aware of the lock-in restrictions when processing orders for this scrip.

Impact Justification

Routine listing of preferential allotment shares for a single company with lock-in provisions. Limited market-wide impact.